tradingkey.logo
搜尋

ATAI Life Sciences NV

ATAI
添加自選
7.350USD
+0.060+0.82%
收盤 09-10 16:00美東
2.72B總市值
虧損本益比TTM

關於 ATAI Life Sciences NV 公司

Atai Beckley NV, formerly ATAI Life Sciences NV, is a clinical-stage biopharmaceutical company. The Company focused on developing treatments for mental health disorders. The Company's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.

ATAI Life Sciences NV 簡介

公司代碼ATAI
公司名稱ATAI Life Sciences NV
上市日期Jun 18, 2021
CEORao (Srinivas G)
員工數量54
證券類型Ordinary Share
年結日Jun 18
公司地址Prof. J.H.Bavincklaan 7
城市AMSTELVEEN
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Netherlands
郵編1183 AT
電話31207932536
網址https://www.atai.com/
公司代碼ATAI
上市日期Jun 18, 2021
CEORao (Srinivas G)

ATAI Life Sciences NV公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Srinivas Rao, M.D., Ph.D.
Dr. Srinivas Rao, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.50K
-6084.06%
Mr. John Hoffman
Mr. John Hoffman
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Robert M. (Rob) Hershberg, M.D., Ph.D.
Dr. Robert M. (Rob) Hershberg, M.D., Ph.D.
Independent Supervisory Director
Independent Supervisory Director
--
--
Mr. Christopher Anderson
Mr. Christopher Anderson
Company Secretary, Director
Company Secretary, Director
--
--
Mr. Jonathan R. Haug
Mr. Jonathan R. Haug
President, Director
President, Director
--
--
Ms. Steffanie Lim-Ho
Ms. Steffanie Lim-Ho
Treasurer
Treasurer
--
--
Mr. Jonathan Groff
Mr. Jonathan Groff
Assistant Secretary
Assistant Secretary
--
--
Ms. Jamie Burnett
Ms. Jamie Burnett
Assistant Secretary
Assistant Secretary
--
--
Ms. Katie Lodato
Ms. Katie Lodato
Assistant Treasurer
Assistant Treasurer
--
--
Mr. Christian Angermayer
Mr. Christian Angermayer
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
-100.00%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Srinivas Rao, M.D., Ph.D.
Dr. Srinivas Rao, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.50K
-6084.06%
Mr. John Hoffman
Mr. John Hoffman
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Robert M. (Rob) Hershberg, M.D., Ph.D.
Dr. Robert M. (Rob) Hershberg, M.D., Ph.D.
Independent Supervisory Director
Independent Supervisory Director
--
--
Mr. Christopher Anderson
Mr. Christopher Anderson
Company Secretary, Director
Company Secretary, Director
--
--
Mr. Jonathan R. Haug
Mr. Jonathan R. Haug
President, Director
President, Director
--
--
Ms. Steffanie Lim-Ho
Ms. Steffanie Lim-Ho
Treasurer
Treasurer
--
--

常見問題

ATAI Life Sciences NV的前五大股東是誰?

ATAI Life Sciences NV的前五大股東如下:Dr. Srinivas Rao, M.D., Ph.D.

有多少機構持有ATAI Life Sciences NV(ATAI)的股份?

截至2026Q1,共有296家機構持有ATAI Life Sciences NV的股份,合計持有的股份價值約為73.07M,占公司總股份的19.93% 。與2025Q4相比,機構持股有所增加,增幅為23428346.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有